|
 Gerald L. Andriole, Jr., M.D.Urology Surgery
Professor, Surgery
Chief, Division of Urologic Surgery
Robert K. Royce Distinguished Professor of Urologic Surgery
Director, Prostate Study Center at Barnes-Jewish Hospital, St. Louis, MO
|
Urology--Certified
Dr. Andriole specializes in urologic oncology, genitourinary oncology, prostate cancer and urologic surgery. His areas of clinical interest include benign prostate hyperplasia, BPH, prostatectomy, laparoscopic radical prostatectomy, PSA, prostate specific antigen, and prostate biopsy.
Jefferson Medical College, Philadelphia, 1978
Residency: Surgery, Strong Memorial Hospital, University of Rochester, Rochester, New York, 1980
Residency: Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 1983
Fellowship: National Cancer Institute, 1985
Center for Advanced Medicine
Urologic Surgery Center
4921 Parkview Place, Suite C, Floor 11
St. Louis, MO 63110
(314) 362-8212
Fax: (314) 361-2203
Barnes-Jewish West County Hospital
Professional Office Building #1
1040 North Mason Road, Suite 122
St. Louis, MO 63141
(314) 996-8060
Progress West HealthCare Center
Suite G
2 Progress Point Parkway
O'Fallon, Missouri 63368
(314) 362-8212
Barnes-Jewish Hospital
Barnes-Jewish West County Hospital
St. Louis Children's Hospital
St. Louis VA Medical Center
Progress West HealthCare Center
National Cancer Institute
1992-2007
Prostate, Lung, Colorectal and Ovarian Cancer Screening Study
National Institutes of Health/National Cancer Institute
2002-2007
Survivor HRQOL and Spouse Satisfaction after Prostate Therapy
National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study
2007, Listed in Best Doctors in America, (Best Doctors, Inc.)
2007, Listed in America's Top Doctors, 7th Edition, Castle Connolly Medical Ltd.
2002, Outstanding Achievement Award, Urologic Oncology Branch, National Cancer Institute
1995, CIAO Award for Medicine
1994, American Urological Association /European Association of Urology International Academic Exchange Program
1988, American Urological Association Audiovisual Award, First Prize, 83rd Annual Meeting
1978, Theodore H. Fetter Award (Urologic Surgery), Jefferson Medical College
Editorial Positions
Associate Editor, The Journal of Men’s Health & Gender, 2003-present
Urology Times, Hands-On Editor, 2002-present
Editor-in-Chief, Yearbook of Urology, 1997-present
Editorial Board, Urology Research and Treatment, 1999-present
Editorial Board, Urologia Internationalis, 1997-present
Editorial Consultant, The Paget Society, 1999-present
The Prostate Journal, 1997-present
Editorial Board, Infections in Urology, 1991-present
Editorial Advisory Board, Surgical Rounds, 1990-present
Special Committees
Steering Committee, Prostate Cancer Chemoprevention Trial, 1992-present
Steering Committee, NIH PLCO Cancer Screening Trial, 1992-present
Chairman, Prostate Subcommittee, NCI, PLCO Cancer Screening Trial, 1993-present
Medical Advisory Committee, Prostate Intervention Versus Observation Trial (PIVOT), 1994-present
Commission on Cancer of the American College of Surgeons, 1994-present
Cochrane Collaboration in Prostatic Diseases, 1995-present
AUA/Pfizer Visiting Professor Review Board, 2001-present
Steering Committee, CAMUS Trial (NIH/NIDDK), 2002-present.
Chairman, Steering Committee, REDUCE Trial (Dutasteride Chemoprevention Trial), 2002-present
NCI, Biorepository Scientific Advisory Panel, 2003-present
Panel Member, Blue Ribbon Prostate Institution, 2004-present
Oral Examiner, Exam Committee, American Board of Urology, 2006-present
Selected Journal Articles and Book Chapters
Andriole GL, Marberger M, Roehrborn CG. Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride. Journal of Urology. 2006;175(5):1657-1662.
Bullock TL, Andriole GL Jr. Emerging drug therapies for benign prostatic hyperplasia. Expert Opin Emerg Drugs. 2006;11(1):111-123.
Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U; PLCO Trial. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. Journal of the National Cancer Institute. 2006;98(4):245-254.
Cross AJ, Peters U, Kirsh VA, Andriole GL, Reding D, Hayes RB, Sinha R. A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Research. 2005;65(24):11779-11784.
Bhayani SB, Andriole GL. Pure laparoscopic radical heminephrectomy and partial isthmusectomy for renal cell carcinoma in a horseshoe kidney: case report and technical considerations. Urology. 2005;66(4):880.
Andriole GL. Prostate specific antigen based prostate cancer screening: accumulating evidence of efficacy but persistent uncertainty. Journal of Urology. 2005;174(2):413-414.
Reisiger K, Tran V, Figenshau RS, Andriole GL, Landman J. Single-setting bilateral laparoscopic renal surgery: assessment of single-stage procedure. Urology. 2005;65(5):892-897; discussion 897.
Andriole GL, Levin DL, Crawford ED, Gelmann EP, Pinsky PF, Chia D, Kramer BS, Reding D, Church TR, Grubb RL, Izmirlian G, Ragard LR, Clapp JD, Prorok PC, Gohagan JK for the PLCO Project Team: Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: Findings from the Initial Screening Round of a Randomized Trial. Journal of the National Cancer Institute. 2005;97(6):433-438.
Pinsky PF, Andriole GL, Kramer B, Hayes R, Prorok P, Gohagan J for the Prostate. Lung, Colorectal and Ovarian Project Team: Prostate Biopsy Following a Positive Screen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Journal of Urology. 2005;173(3):746-751.
Iczkowski KA, Qiu J, Qian J, Somerville MC, Rittmaster RS, Andriole GL, Bostwick DG. The dual 5-alpha-reductase inhibitor dutasteride induces atrophic changes and decreases relative cancer volume in the human prostate. Urology. 2005;65(1):76-82.
Anast JW, Andriole GL, Bismar TA, Yan Y, Humphrey PA. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Urology. 2004;64(3):544-550.
Andriole GL, Roehrborn C, Schulman C, Slawin KM, Somerville M, Rittmaster RS. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. Urology. 2004;64(3):537-541; discussion 542-543.
Andriole GL, Humphrey P, Ray P, Gleave ME, Trachtenberg J, Thomas LN, Lazier CB, Rittmaster RS. Effect of the dual 5alpha-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer. Journal of Urology. 2004;172(3):915-919.
Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK; PLCO Steering Committee. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. Urologic Oncology. 2004;22(4):358-361.
Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB. Risk behaviours and benign prostatic hyperplasia. BJU Int. 2004;93(9):1241-1245.
Pub Med page for Gerald L. Andriole, Jr., M.D.
Andriole GL and Colberg JW. Surgical Management of Penile Cancer. In: NJ Vogelzang (ed.). Comprehensive Textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins; 1996.
Andriole GL, Keetch DW, Dehner LP, Ratliff, TL. Superficial Bladder Cancer. Current Problems in Urology. Lipshultz LI (ed.). St. Louis: Mosby; 1992.
|
|
|
